Pernix Therapeutics Holdings Inc is a specialty pharmaceutical company, focuses on the acquisition, development, and commercialization of prescription drugs. It aims at underserved therapeutic areas, such as central nervous system, including neurology, pain, and psychiatry. Its products include Treximet used to treat acute migraine; Zohydro ER with BeadTek, an extended-release opioid agonist indicated used in case of severe pain; Silenor for the treatment of insomnia characterized by difficulty with sleep maintenance, and Khedezla for major depressive disorder. Geographically all the operations are functioned though the United States, however also has a business presence in international market.
